PATENT CLAIM ANALYSIS

Application Number: 16325669
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-07
Patent Classification: ["549", "040000"]

Abstract:
The present invention relates to a compound for treating a degenerative disease of central nervous system or a brain tumor, a composition and a use thereof, wherein the compound has the structure of Formula I. These compounds can be used as SGK1 and JNK dual inhibitors with antioxidant effect, which can be formulated into suitable formulations for treating a degenerative disease of central nervous system or a brain tumor.

Claim (Index 6):
A SGK1 and JNK dual inhibitor having antioxidant effect, comprising any of the compounds or the pharmaceutically acceptable salts thereof of  claim 1 .

Metadata:
- Claim Count in Document: 7.0
- Percentile: 99.0
- Lexical Diversity: 1.54167
- Patent Class: 549.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15037466', '12404413', '14824096', '13400586', '12180408']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6624024657443592
- 35 USC 102 Novelty (BERT): 0.5135195747000574
- Combined Prediction Score: 0.647514176639929
- Mean Citation Score: 202.331038
- Max Citation Score: 207.79
- Similarity Product: 119.46069441974166

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test